Fabrication of Nano-TiO2 Coating for Dye-Sensitized Solar Cell by Vacuum Cold Spraying at Room Temperature

Deposition of nanocrystalline TiO₂ coating at low temperature is becoming more attractive due to the possibility for continuous roll production of the coating for assembly lines of dye-sensitized solar cell (DSC) at a low cost. In this study, porous nano-TiO₂ coating was deposited by vacuum cold spraying (VCS) at room temperature on a conducting glass substrate using commercial P25 nanocrystalline TiO₂ powder. The microstructure of TiO₂ coating was characterized by field emission scanning electron microscopy (FESEM) and nitrogen adsorption test. A commercial dye (N719) was adsorbed on the surface of TiO₂ particles within the coating to assemble a DSC. The cell performance was evaluated by employing simulated solar light at an intensity of 100 mW/cm². The results showed that TiO₂ coating was deposited by the agglomerates of nano-TiO₂ powders. The Brunauer-Emmett-Teller (BET) test of the as-sprayed TiO₂ coating yielded a porosity of 49% and an average pore size of 17 nm. The assembled solar cell yielded a short-circuit current density of 7.3 mA/cm² and an energy conversion efficiency of 2.4%. The test results indicate that VCS was a promising method to deposit nanocrystalline TiO₂ coatings at low temperature applied to DSCs. This article is an invited paper selected from presentations at the 2007 International Thermal Spray Conference and has been expanded from the original presentation. It is simultaneously published in Global Coating Solutions, Proceedings of the 2007 International Thermal Spray Conference, Beijing, China, May 14-16, 2007, Basil R. Marple, Margaret M. Hyland, Yuk-Chiu Lau, Chang-Jiu Li, Rogerio S. Lima, and Ghislain Montavon, Ed., ASM International, Materials Park, OH, 2007.     

Intermediate temperature solid oxide fuel cell based on fully integrated plasma-sprayed components

This work addresses the fabrication of membrane-type solid oxide fuel cells (SOFCs) operating at medium temperatures, where all components are fabricated by plasma spray technology, and the evaluation of the performance of the SOFC single unit in a temperature range of 500 to 800 °C. Single cells composed of LaSrMgO₃ cathodes, LaSrGaMgO₃ (LSGM) electrolytes, and Ni/yttria-stabilized zirconia anodes were fabricated in successive atmospheric plasma-spraying processes. Plasma-spraying processes have been optimized and tailored to each layer to achieve highly porous cathode and anode layers as well as high-density electrolyte layers. A major effort has been devoted to the production of the LSGM electrolyte that has a high density and is free of cracks. Electrochemical impedance spectroscopy was used to investigate the conductivity of the electrode layers, and particularly the resistance of the electrolyte layer. It revealed that the heat treatment had a great influence on the specific conductivity of the sprayed electrolyte layers and that the specific conductivity of the heat-treated layers was dramatically increased to the same magnitude as is typical for sintered LSGM pellets. The experimental results have demonstrated that the plasma-spraying process has a great potential for the integrated fabrication of medium-temperature SOFC units. The original version of this article was published as part of the ASM Proceedings, Thermal Spray 2003: Advancing the Science and Applying the Technology, International Thermal Spray Conference (Orlando, FL), May 5–8, 2003, Basil R. Marple and Christian Moreau, Ed., ASM International, 2003.     

二元稀土系AB5型贮氢电极合金的放电容量与晶胞体积和4f电子浓度的关系

制备了6个系列通式为AαA‘1-αB5的RE(NiCoMnTi)5贮氢电极合金(其中，AαA‘1-α为La，Ce，Pr，Nd4个元素中任意2个的组合)，测定了它们在100次循环中的最大放电容量Cmax及部分合金的晶胞体积Vcell．结果表明：Cmax主要由Vcell决定，Cmax先随Vcell的增大而增加，在Vcell≈85．66x10^-^3。nm^3时达到一极大值，然后又随Vcell的增大而减小；同时，Cmax还与4f电子浓度ne4f／naRE有关，A侧具有相同4f电子浓度的合金其Cmax随4f电子浓度的变化趋势相似．     

Multi-Omics Revealed Molecular Mechanisms Underlying Guard Cell Systemic Acquired Resistance

Systemic Acquired Resistance (SAR) improves immunity of plant systemic tissue after local exposure to a pathogen. Guard cells that form stomatal pores on leaf surfaces recognize bacterial pathogens via pattern recognition receptors, such as Flagellin Sensitive 2 (FLS2). However, how SAR affects stomatal immunity is not known. In this study, we aim to reveal molecular mechanisms underlying the guard cell response to SAR using multi-omics of proteins, metabolites and lipids. Arabidopsis plants previously exposed to pathogenic bacteria Pseudomonas syringae pv. tomato DC3000 (Pst) exhibit an altered stomatal response compared to control plants when they are later exposed to the bacteria. Reduced stomatal apertures of SAR primed plants lead to decreased number of bacteria in leaves. Multi-omics has revealed molecular components of SAR response specific to guard cells functions, including potential roles of reactive oxygen species (ROS) and fatty acid signaling. Our results show an increase in palmitic acid and its derivative in the primed guard cells. Palmitic acid may play a role as an activator of FLS2, which initiates stomatal immune response. Improved understanding of how SAR signals affect stomatal immunity can aid biotechnology and marker-based breeding of crops for enhanced disease resistance.     

The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection

Diabetes mellitus is a group of heterogeneous metabolic disorders characterized by chronic hyperglycaemia mainly due to pancreatic β cell death and/or dysfunction, caused by several types of stress such as glucotoxicity, lipotoxicity and inflammation. Different patho-physiological mechanisms driving β cell response to these stresses are tightly regulated by microRNAs (miRNAs), a class of negative regulators of gene expression, involved in pathogenic mechanisms occurring in diabetes and in its complications. In this review, we aim to shed light on the most important miRNAs regulating the maintenance and the robustness of β cell identity, as well as on those miRNAs involved in the pathogenesis of the two main forms of diabetes mellitus, i.e., type 1 and type 2 diabetes. Additionally, we acknowledge that the understanding of miRNAs-regulated molecular mechanisms is fundamental in order to develop specific and effective strategies based on miRNAs as therapeutic targets, employing innovative molecules.     

Platelet-Rich Plasma Promotes the Proliferation of Human Keratinocytes via a Progression of the Cell Cycle. A Role of Prolidase

Although the role of platelet-rich plasma (PRP) in tissue regeneration has been confirmed in many studies, the mechanism of this process is still not fully understood. Human keratinocytes (HaCaT) cells were used as an experimental model for studies on the effects of PRP on cell proliferation, migration, collagen biosynthesis, prolidase activity, and its expression and anabolic signaling. The activation of epidermal growth factor receptor (EGFR), β₁-integrin, and insulin-like growth factor-1 receptor (IGF-1R) by PRP were investigated by western blot and immunocytochemistry. It has been found that PRP induced keratinocytes migration and proliferation through activation of cell cycle progression and EGFR downstream signaling. Similar biological effects were achieved by an addition to the culture medium of prolidase (PEPD), a ligand of EGFR (PRP is a rich source of PEPD–2 ng/mL). PRP-dependent stimulation of collagen biosynthesis was accompanied by an increase in the expression of NF-κβ, IGF-1R-downstream signaling proteins, and PEPD activity. The data suggest that PRP activates a complex of growth factors and adhesion receptors that stimulate cell proliferation, migration, and collagen biosynthesis. PRP induces PEPD-dependent human keratinocyte proliferation through activation of the EGFR receptor. Our study provides a novel mechanism of PRP-dependent wound healing.     

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth

Cripto-1 is a member of the EGF-CFC/FRL1/Cryptic family and is involved in embryonic development and carcinogenesis. We designed a novel anti-Cripto-1 artificial antibody and assessed the recognition to the antigen and the potential to suppress the growth of cancer stem cells. First, single chain antibody clones were isolated by bio-panning with the affinity to recombinant Cripto-1 protein from our original phage-display library. Then, the variable regions of heavy chain VH and light chain VL in each clone were fused to constant regions of heavy chain CH and light chain CL regions respectively. These fused genes were expressed in ExpiCHO-S cells to produce artificial humanized antibodies against Cripto-1. After evaluation of the expression levels, one clone was selected and the anti-Cripto-1 antibody was produced and purified. The purified antibody showed affinity to recombinant Cripto-1 at 1.1 pmol and immunoreactivity to cancer tissues and cell lines. The antibody was available to detect the immunoreactivity in tissue microarrays of malignant tumors as well as in Cripto-1 overexpressing cells. Simultaneously, the antibody exhibited the potential to suppress the growth of human colon cancer derived GEO cells overexpressing Cripto-1 with IC₅₀ at approximately 110 nM. The artificially humanized antibody is proposed to be a good candidate to target cancer cells overexpressing Cripto-1.     

Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts

Cancer-associated fibroblasts (CAFs) are one of the most abundant and critical components of the tumor stroma. CAFs can impact many important steps of cancerogenesis and may also influence treatment resistance. Some of these effects need the direct contact of CAFs and cancer cells, while some involve paracrine signals. In this study, we investigated the ability of head and neck squamous cell carcinomas (HNSCC) patient-derived CAFs to promote or inhibit the colony-forming ability of HNSCC cells. The effect of cisplatin on this promoting or inhibiting influence was also studied. The subsequent analysis focused on changes in the expression of genes associated with cancer progression. We found that cisplatin response in model HNSCC cancer cells was modified by coculture with CAFs, was CAF-specific, and different patient-derived CAFs had a different “sensitizing ratio”. Increased expression of VEGFA, PGE2S, COX2, EGFR, and NANOG in cancer cells was characteristic for the increase of resistance. On the other hand, CCL2 expression was associated with sensitizing effect. Significantly higher amounts of cisplatin were found in CAFs derived from patients who subsequently experienced a recurrence. In conclusion, our results showed that CAFs could promote and/or inhibit colony-forming capability and cisplatin resistance in HNSCC cells via paracrine effects and subsequent changes in gene expression of cancer-associated genes in cancer cells.